G. Heering

Acute Myeloid Leukemia Patients Requiring Two Cycles of Intensive Induction for Attainment of Remission Experience Inferior Survival Compared with Patients Requiring a Single Course of Induction Chemotherapy.

A. Nagler, A. Shimoni, J. Canaani, 2021, Clinical lymphoma, myeloma & leukemia.

Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocol

A. Nagler, A. Shimoni, V. Marcu-Malina, 2022, Annals of Hematology.

ELN 2017 classification significantly impacts the risk of early death in acute myeloid leukemia patients receiving intensive induction chemotherapy

A. Nagler, A. Shimoni, J. Canaani, 2022, Annals of Hematology.

Contemporary evaluation of acute myeloid leukemia patients with long‐term survival exceeding 5 years

A. Nagler, D. Dominissini, A. Shimoni, 2022, European journal of haematology.

Evaluation of the clinical impact of bone marrow cultures in current medical practice

A. Nagler, A. Toren, G. Rahav, 2022, Scientific reports.